AS39495
Xelya SAS
AS39495 is Xelya SAS (colibriwithus.com). It announces 512 IPv4 addresses in 2 prefixes, and 0 IPv6 prefixes.
France· RIPE· allocated 2006-03-07· hosting
512
IPv4 addresses announced
2
IPv4 prefixes
0
IPv6 prefixes
0.00%
of its routes RPKI-valid
512
of its IPv4 geolocated
1
country
Where its space is
The IPv4 it announces that IP Geolocation places, by country. A /24 counts for the AS announcing most of it.
- France512 · 100.00%
Registry record
Its ASN Whois record, as the registry publishes it.
- handle
- COLIBRI-SOLUTIONS
- name
- Xelya SAS
- org
- ORG-CSS22-RIPE
- org name
- Xelya SAS
- org address
- 174 Bureaux de la Colline, 92213, Saint Cloud Cedex, FRANCE
- org country
- FR
- country
- FR
- source
- ripe
- status
- ASSIGNED
- created
- 2006-03-07
- updated
- 2018-09-04
- maintainer
- RIPE-NCC-END-MNT|CLBR-MNT
- abuse name
- Service Operations
- abuse email
- gestion@colibriwithus.com
- abuse kind
- role
What the databases see
Addresses each address-keyed database holds in the IPv4 it announces, as a share of that space, with its largest providers. Counts overlap.
- VPN IP183.52%
- None here
- None here
- None here
- None here
- None here
- Hosting IP51199.80%
- None here
- None here
- None here
- 0.20%
- 0.59%
- None here
IPv4 prefixes
Every IPv4 prefix BGP Route saw it announce. A prefix another AS also announces says so.
| PREFIX | COUNTRY | RPKI | PEERS | FIRST SEEN |
|---|---|---|---|---|
| 185.29.180.0/24 | France | not found | 16 | 2026-10-02 |
| 194.50.29.0/24 | France | not found | 16 | 2026-10-02 |
00 · Evaluate
Test the real build first.
An evaluation license puts a full current build in your hands, with no sampling, so you can measure it against your own traffic before anyone talks about terms.
01 · License
Then license what you use.
Standard, for detection and decisions inside your own product and operations.
Redistribution, when the data ships onward inside what you sell, priced by scope rather than by seat.
Annual terms, a named contact, and monthly, quarterly or yearly payment.